CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
MyEllevate Proceduredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05590039
NCT05590039N/ACompleted
CompareCT.gov

Prospective Clinical Study To Evaluate The Safety And Efficacy Of The MyEllevate® Procedure

Cynosure, Inc.·interventional·Posted Oct 21, 2022·Updated Aug 20, 2024

In Brief

A clinical study evaluating MyEllevate Procedure for Soft Tissue Approximation and 2 related conditions. Completed, enrolled 10 participants across 2 sites.

Detailed Summary

The intended purpose of the MyEllevate® procedure used in this study is to assess the safety and efficacy of the procedure for soft tissue approximation and elevation of sub dermis and underlying muscle of the submentum \& jawline.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSoft Tissue Approximation, Elevation of Subdermis, Elevation of Underlying Muscle
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 21, 2022
Enrollment StartJul 8, 2022
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 3.7 years ago

Interventions

MyEllevate Proceduredevice

The defined study area will be identified and may be marked with a surgical marker. A local tumescent anesthetic, such as lidocaine, will be injected to the area prior to the procedure. The MyEllevate® device will be used in accordance with the Instructions for Use (IFU) manual for soft tissue approximation and elevation of sub dermis and underlying muscle of the submentum and jawline.